Board of Directors
Acarix’s board of directors is the highest decision-making body after the general meeting of shareholders.
Werner Braun
Chairman of the Board and board member since 2016.
Background
Dr. Werner Braun has long-term international experience from leading positions in MedTech companies in Germany, Austria, Switzerland and the United States. Dr. Braun has a PhD in physics from the Technical University of Munich, Germany. He is currently Chairman of the Board and assigned CEO of Miracor Medical Systems GmbH and the CEO of WEMANITEC GmbH. In the past five years, Dr. Braun has been the CEO of BIOTRONIK SE & Co. and an external board member of Technologies Ltd. Chilworth.
Acarix holdings
Shares: 25 600
Warrants: 20 000
Anders Jacobson
Board member since 2020.
Background
Anders Jacobson has extensive experience within the R&D field and for more than 15 years Anders has held various senior positions in different life science companies like Biotage and St Jude medical and within the technical consulting industry (Eg Sigma, Teleca, Prevas). In his previous positions, Anders has worked in leading positions in research and development, manufacturing, service, and technical sales in a global environment. Anders has a MSc in engineering physics from Uppsala University, Sweden.
Acarix holdings
Shares: 0
Warrants: 0
Paolo Raffaelli
Board member since 2019.
Background
Paolo Raffaelli has over 20 years of management experience in commercial international positions in both sales and marketing. Paolo’s latest assignment was Marketing and Education Director EMEA at Abbott for the Cardiac Rhythm Management business. Previously Paolo worked as Global Marketing VP for Maquet Critical Care, and before that he was over 12 years with Medtronic, covering several business and marketing management roles in the CRM and Interventional Cardiology business areas, including the general manager role for Medtronic Sweden. Paolo holds an MBA from IMD Business School in Lausanne, Switzerland and lives with his family in Stockholm, Sweden.
Acarix holdings
Shares: 0
Warrants: 0
Marlou Janssen-Counotte
Board member since 2020
Background
Marlou Janssen is a seasoned senior executive with more than 25 years experience in the Medtech industry. For three decades she has worked in many regions around the world building solutions in vascular, cardiology, electrophysiology and neuromodulation therapies for global companies. With her roots in clinical education, Marlou believes industry should give back to the medical and patient communities in responsible, ethical and highly impactful ways. Marlou started her Medtech career at Medtronic and in the past 20 years she held senior executive roles as Vice President at St Jude Medical, Vice President International Marketing & Sales at Biotronik and President Biotronik US.
In February 2019 Marlou joined Philips Medical Systems where she now leads a new Venture for Philips called EPD Solutions.
Acarix holdings
Shares: 0
Warrants: 0
Johanne Louise Brændgaard
Board member since 2018.
Background
Johanne Louise Brændgaard has long experience of global sales, marketing and product management from the MedTech industry from positions in Cook Medical and Getinge. Before entering the MedTech industry, she worked in venture capital and IT. Brændgaard has an MSc in international business economics from Aalborg University in Denmark.
Acarix holdings
Shares: 0
Warrants: 0
Ulf Rosén
Partner. Board member since 2014.
Background
Ulf Rosén is General Partner at the investment company SEED Capital, responsible for investments in medical technology and digital health solutions. Since the late 1990s, he has been Chairman of the Board, board member and CEO in several Scandinavian companies in the medical technology, pharma and service sectors. Mr. Rosén’s earlier assignments include CEO of NeoPharma AB (trade sale), CEO Attana AB (asset transfer), Chairman of the Board in Trial Form Support International (partial exit to PE), member of the board in Observe Medical AB (trade sale), General Manager of Fresenius-Kabi AB, Deputy CEO of the Global Nutrition Division of Fresenius-Kabi, CEO of Pharmacia & Upjohn AS and CEO of Globen Ögonklinik AB. He is one of three owners of SEED Capital Management.
Acarix holdings
Shares: 965 830
Warrants: 0